Charles River Laboratories, Inc. DBA Charles River, Endosafe's Complete FDA Record

FDA action counts

Enforcement history

On 2026-03-27, Argus HQ recorded an FDA Form 483 inspection citation for Charles River Laboratories, Inc. DBA Charles River, Endosafe, rated "high" severity in Argus HQ's classification: Charles River Laboratories, Inc. DBA Charles River, Endosafe -- FDA 483: 1 observation (2026-03-27). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Charles River Laboratories, Inc. DBA Charles River, Endosafe has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

Is this FDA enforcement data for Charles River Laboratories, Inc. DBA Charles River, Endosafe official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Charles River Laboratories, Inc. DBA Charles River, Endosafe had?

Argus HQ has recorded 1 FDA events for Charles River Laboratories, Inc. DBA Charles River, Endosafe: 0 warning letters, 0 recalls, 0 approvals, and 1 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Charles River Laboratories, Inc. DBA Charles River, Endosafe?

The most recent FDA event Argus HQ has on file for Charles River Laboratories, Inc. DBA Charles River, Endosafe is dated 2026-03-27, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Charles River Laboratories, Inc. DBA Charles River, Endosafe automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Charles River Laboratories, Inc. DBA Charles River, Endosafe is observed, this page's event count and history update automatically.

Related enforcement actions

• Charles River Laboratories, Inc. DBA Charles River, Endosafe -- FDA 483: 1 observation (2026-03-27) →

Compare with

• Charles River Laboratories, Inc. DBA Charles River, Endosafe vs Philips North America
• Charles River Laboratories, Inc. DBA Charles River, Endosafe vs Medline Industries, LP
• Charles River Laboratories, Inc. DBA Charles River, Endosafe vs Boston Scientific Corporation
• Charles River Laboratories, Inc. DBA Charles River, Endosafe vs Baxter Healthcare Corporation
• Charles River Laboratories, Inc. DBA Charles River, Endosafe vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.